We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Conference To Discuss Lab's Role in Managing Infectious Diseases

By LabMedica International staff writers
Posted on 24 Feb 2009
The American Association of Clinical Chemistry (AACC), the Association of Public Health Laboratories (APHL), and the U.S. More...
Centers for Disease Control & Prevention (CDC; Atlanta, GA, USA) will cosponsor a one-day conference on Tuesday, April 28, 2009, in Atlanta, GA (USA). The conference is titled, "The Lab's Changing Role in Managing Infectious Diseases."

Speakers will discuss recent advances in infectious disease testing, which have provided the core laboratory with opportunities to take a more prominent role in the care of patients with infectious, and sexually transmitted, diseases. The size of the current and future market for ID testing, antimicrobial resistance, validating laboratory tests, emerging molecular platforms, and managing infectious risk in the clinical laboratory are among the topics to be presented at the conference.

The American Association for Clinical Chemistry (AACC; Washington DC, USA) is a professional society dedicated to improving healthcare through laboratory medicine.

The conference is being supported in part by an educational grant from Siemens Healthcare Diagnostics (Deerfield, IL, USA), a leading clinical diagnostics company. Siemens offers products and services designed for efficient delivery of patients test results, for diagnosing medical conditions, and monitoring therapy.

For further information about the conference e-mail Peter Patterson.

Related Links:
Conference Information – Peter Patterson
The American Association for Clinical Chemistry
U.S. Centers for Disease Control & Preventio
Siemens Healthcare Diagnostics



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
HPV Molecular Test
BD Onclarity HPV Assay
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.